Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Who Should Avoid It Pregnancy or breastfeeding Pre-existing metabolic conditions (consult healthcare provider) Stop Right Away If You Notice Severe gastrointestinal upset or persistent nausea Unusual fatigue or weakness (opposite of expected effect) Persistent headaches or dizziness Sleep disturbances or insomnia Allergic reactions (rash, swelling, difficulty breathing) Significant mood changes or anxiety Milder Signs to Watch For How Long Should a 5-Amino-1MQ Cycle Last
Who should avoid GHK-Cu entirely Wilson's disease or any copper metabolism disorder Active malignancy until more evidence exists Pregnancy and breastfeeding Known copper sensitivity Anyone unable to maintain sterile technique for injection When unsure, talk to us before starting anything
In animal studies, yes
Egras AM, Hamilton WR, Lenz TL, Monaghan MS
Patients should be reviewed 812 weeks after commencing treatment to assess: Symptomatic improvement, particularly resolution of fatigue and neurological symptoms Haematological response (normalisation of haemoglobin and mean cell volume) Reticulocyte count typically rises within one week, indicating bone marrow response Repeat serum B12 testing is generally not useful after starting parenteral therapy, as levels remain elevated for months
US$ 26.89
US$ 21.59
US$ 22.68
US$ 22.22
US$ 20.11
US$ 29.40
US$ 21.66
US$ 27.10
US$ 23.44